{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=66", "query": { "intervention": "CTRL", "page": 66 }, "page_size": 10 }, "pagination": { "page": 66, "page_size": 10, "total_count": 26651, "total_pages": 2666, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=67&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=65&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-08T10:39:26.985Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06775379", "title": "A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Azetukalner", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Xenon Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 450, "start_date": "2024-12-20", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-11-08T10:39:26.985Z", "location_count": 45, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Rogers, Arkansas + 38 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Irvine", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06775379" }, { "nct_id": "NCT00001146", "title": "Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bipolar Disorder", "Involutional Depression", "Mood Disorder" ], "interventions": [ { "name": "Ethyl Eicosapentaenoic Acid", "type": "DRUG" }, { "name": "OmegaBrite", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Mental Health (NIMH)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 240, "start_date": "1999-10", "completion_date": "2002-08", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-11-08T10:39:26.985Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001146" }, { "nct_id": "NCT03056846", "title": "Probiotics on Stress-associated Gastrointestinal Function in University Students", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Placebo", "type": "DIETARY_SUPPLEMENT" }, { "name": "Probiotic Combination", "type": "DIETARY_SUPPLEMENT" }, { "name": "Bifidobacterium bifidum", "type": "DIETARY_SUPPLEMENT" }, { "name": "Bifidobacterium longum", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 634, "start_date": "2017-09-05", "completion_date": "2018-02-05", "has_results": false, "last_update_posted_date": "2019-03-25", "last_synced_at": "2026-11-08T10:39:26.985Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03056846" }, { "nct_id": "NCT00114686", "title": "Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar I Disorder", "Alcohol Dependence" ], "interventions": [ { "name": "Quetiapine fumarate", "type": "DRUG" }, { "name": "lithium", "type": "DRUG" }, { "name": "divalproex", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "21 Years to 60 Years" }, "enrollment_count": 350, "start_date": "2006-01", "completion_date": "2007-04", "has_results": false, "last_update_posted_date": "2013-01-04", "last_synced_at": "2026-11-08T10:39:26.985Z", "location_count": 38, "location_summary": "Cerritos, California • San Diego, California • New Haven, Connecticut + 35 more", "locations": [ { "city": "Cerritos", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Maitland", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00114686" }, { "nct_id": "NCT01246583", "title": "CP-690-550 Ointment For Chronic Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "CP-690,550 Ointment 1", "type": "DRUG" }, { "name": "Vehicle 1", "type": "DRUG" }, { "name": "CP-690,550 Ointment 2", "type": "DRUG" }, { "name": "Vehicle 2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 71, "start_date": "2011-02-16", "completion_date": "2011-11-29", "has_results": true, "last_update_posted_date": "2021-01-11", "last_synced_at": "2026-11-08T10:39:26.985Z", "location_count": 8, "location_summary": "Mobile, Alabama • Los Angeles, California • Orange Park, Florida + 4 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange Park", "state": "Florida" }, { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT01246583" }, { "nct_id": "NCT07306754", "title": "A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "ABBV-243", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 66, "start_date": "2025-12-17", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-01-12", "last_synced_at": "2026-11-08T10:39:26.985Z", "location_count": 1, "location_summary": "Grayslake, Illinois", "locations": [ { "city": "Grayslake", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07306754" }, { "nct_id": "NCT01461460", "title": "A Thorough QT Study of TR-701free Acid (FA) in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer" ], "interventions": [ { "name": "TR-701 FA 1200 mg", "type": "DRUG" }, { "name": "Moxifloxacin 400 mg", "type": "DRUG" }, { "name": "TR-701 FA 200 mg plus Placebo", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 48, "start_date": "2011-11-28", "completion_date": "2011-12-23", "has_results": false, "last_update_posted_date": "2018-12-05", "last_synced_at": "2026-11-08T10:39:26.985Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01461460" }, { "nct_id": "NCT02173379", "title": "Absorb IV Randomized Controlled Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease", "Coronary Artery Stenosis", "Coronary Disease", "Coronary Stenosis" ], "interventions": [ { "name": "Absorb BVS", "type": "DEVICE" }, { "name": "XIENCE", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Abbott Medical Devices", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2604, "start_date": "2014-07", "completion_date": "2022-04-06", "has_results": true, "last_update_posted_date": "2023-10-30", "last_synced_at": "2026-11-08T10:39:26.985Z", "location_count": 98, "location_summary": "Birmingham, Alabama • Chandler, Arizona • Gilbert, Arizona + 82 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02173379" }, { "nct_id": "NCT01993888", "title": "The EVARREST® Fibrin Sealant Patch Liver Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hemorrhage" ], "interventions": [ { "name": "EVARREST® Fibrin Sealant Patch", "type": "BIOLOGICAL" }, { "name": "Standard of Care (SoC)", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Ethicon, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 102, "start_date": "2013-10", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2016-07-11", "last_synced_at": "2026-11-08T10:39:26.985Z", "location_count": 10, "location_summary": "Birmingham, Alabama • Augusta, Georgia • Chicago, Illinois + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01993888" }, { "nct_id": "NCT07409103", "title": "A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Active Rheumatoid Arthritis" ], "interventions": [ { "name": "ELV001 25 mg", "type": "DRUG" }, { "name": "ELV001 75 mg", "type": "DRUG" }, { "name": "ELV001 125 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Elevara Medicines Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 180, "start_date": "2026-02-18", "completion_date": "2028-03-31", "has_results": false, "last_update_posted_date": "2026-10-23", "last_synced_at": "2026-11-08T10:39:26.985Z", "location_count": 22, "location_summary": "Gilbert, Arizona • Glendale, Arizona • Tucson, Arizona + 18 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tustin", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07409103" } ] }